NDC 0641-6006-01 - Atropine Sulfate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0641-6006
- Requested NDC
- 0641-6006-01
- Package NDCs from labels
- 0641-6006-01, 0641-6006-10
- Manufacturer
- Hikma Pharmaceuticals USA Inc.
- Effective date
- 2024-04-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Atropine Sulfate Injection, USP | Hikma Pharmaceuticals USA Inc. | 2024-04-08 | HUMAN PRESCRIPTION DRUG LABEL |
| Atropine Sulfate - Medical Purchasing Solutions, LLC | Medical Purchasing Solutions, LLC | 2023-05-31 | HUMAN PRESCRIPTION DRUG LABEL |
| Atropine Sulfate - General Injectables & Vaccines, Inc | General Injectables & Vaccines, Inc | 2022-12-09 | HUMAN PRESCRIPTION DRUG LABEL |
| Atropine Sulfate Injection, USP FOR IM, IV, OR SC USE Rx Only | Henry Schein, Inc. | 2022-01-09 | HUMAN PRESCRIPTION DRUG LABEL |
| ATROPINE SULFATE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2020-09-04 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0641-6006-01 | Atropine Sulfate | 20 mL in 1 VIAL | INJECTION | 20 | 4 | |
| 0641-6006-10 | Atropine Sulfate | 10 in 1 CARTON | INJECTION | 10 | 4 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0641-6006-01 | ML - Milliliter | 0641-6006 | 0dd1cebf-afb5-463c-8066-2ae1248537db | 1 | 2012-07-24 |
| 0641-6006-10 | ML - Milliliter | 0641-6006 | 50fad021-aa7f-43ab-b295-6c10da590ef3 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| ATROPINE SULFATE | ACTIVE INGREDIENT | 03J5ZE7KA5 | ATROPINE SULFATE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 | |
| Atropine Sulfate | ACTIVE INGREDIENT | 03J5ZE7KA5 | ATROPINE SULFATE INJECTION [GENERAL INJECTABLES & VACCINES, INC] | 1 | |
| ATROPINE | ACTIVE MOIETY | 7C0697DR9I | ATROPINE SULFATE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 | |
| Atropine | ACTIVE MOIETY | 7C0697DR9I | ATROPINE SULFATE INJECTION [GENERAL INJECTABLES & VACCINES, INC] | 1 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | ATROPINE SULFATE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | ATROPINE SULFATE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 | |
| SULFURIC ACID | INACTIVE INGREDIENT | O40UQP6WCF | ATROPINE SULFATE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | ATROPINE SULFATE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Medi-First Plus First Aid Eye Wash | WATER | Unifirst First Aid Corporation | d7ea80ca-b4a0-4476-8b50-b3425c6d456a | 2025-09-08 | Warnings | 059QF0KO0R |
| ECOLAB Eye Wash | PURIFIED WATER | ECOLAB Food Safety Specialties, Inc. | 4bcfa21a-791e-4d04-e054-00144ff88e88 | 2025-09-08 | Warnings | 059QF0KO0R |
| Physicians Care Eyewash | EYEWASH | Acme United Corporation | 3e239b12-9a75-339d-e063-6294a90a72ae | 2025-09-06 | Warnings | 059QF0KO0R |
| Polyethylene Glycol 3350 and electrolytes - Unflavored | POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES - UNFLAVORED | Strides Pharma Science Limited | 48c741a9-9039-4fdb-a875-86d4ea968282 | 2025-09-05 | Warnings, Adverse reactions | 451W47IQ8X |
| Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate and Potassium Chloride - Unflavored | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE - UNFLAVORED | Strides Pharma Science Limited | 37c111ec-5b62-42b9-bbb2-3b0c530e34c9 | 2025-09-01 | Warnings, Adverse reactions | 451W47IQ8X |
| Sterile Water | WATER INJECTION | Henry Schein, Inc. | 3501952b-b556-4d5e-b81b-5c35ff87b475 | 2025-08-28 | Warnings, Adverse reactions | 059QF0KO0R |
| Dextrose and Sodium Chloride | DEXTROSE AND SODIUM CHLORIDE | Baxter Healthcare Company | dcbf1907-1841-4afc-ab5d-a9893a2d7256 | 2025-08-26 | Warnings, Adverse reactions | 451W47IQ8X |
| terrasil Fast and Natural Wart Removal | GRAPHITE 10X, NATRUM MURIATICUM 3X, SYMPHYTUM OFFICINALE (COMFREY) 1X, THUJA OCCIDENTALIS 3X | Aidance Scientific, Inc. | 3d367c0f-5a28-eded-e063-6394a90ad2dc | 2025-08-25 | Warnings | 451W47IQ8X |
| Cold Sore Treatment Extra Strength | ECHINACEA ANGUSTIFOLIA WHOLE, SODIUM CHLORIDE, THUJA OCCIDENTALIS LEAFY TWIG, AND CALENDULA OFFICINALIS FLOWERING TOP | Forces of Nature | 0a5d32dc-c0e7-404e-85f2-6c3a338560ba | 2025-08-22 | Warnings | 451W47IQ8X |
| Incontinence | ALOE, ARG. NIT., ARSENICUM ALB., BELLADONNA, BENZOICUM ACIDUM, BRYONIA, CANTHARIS, CAUSTICUM, EQUISETUM HYEMALE, FERRUM METALLICUM, GELSEMIUM, IGNATIA, KALI PHOS., LYCOPODIUM, NAT. MUR., NITRICUM AC., PLANTAGO, PULSATILLA, RHUS AROMATICA , SABAL, SECALE, SEPIA, STAPHYSAG.,STRAMONIUM, THYROIDINUM, VERBASCUM, ECHINACEA, HYDRASTIS | Newton Laboratories, Inc. | 994cbc8e-a221-1548-e053-2995a90a1f7f | 2025-08-20 | Warnings | 451W47IQ8X |
| Fungus Fighter | CANDIDA ALBICANS, SANICULA, TELLURIUM METALLICUM, TORULA CEREVISIAE, ANTIMON. CRUD., ARSENICUM ALB., BARYTA CARB., BRYONIA, CALC. CARB., CARBO VEG., CUPRUM MET., DULCAMARA, GRAPHITES, KALI CARB., LACHESIS, LYCOPODIUM, MEZEREUM, NITRICUM AC., PHOSPHORUS, PHYTOLACCA, SEPIA, SILICEA, SULPHUR, SULPHURICUM AC., ZINC. MET., APIS MEL., THUJA OCC. | Newton Laboratories, Inc. | 93e05175-001b-c639-e053-2a95a90a289c | 2025-08-19 | Warnings | O40UQP6WCF |
| Fungus Fighter | CANDIDA ALBICANS, SANICULA, TELLURIUM METALLICUM, TORULA CEREVISIAE, ANTIMON. CRUD., ARSENICUM ALB., BARYTA CARB., BRYONIA, CALC. CARB., CARBO VEG., CUPRUM MET., DULCAMARA, GRAPHITES, KALI CARB., LACHESIS, LYCOPODIUM, MEZEREUM, NITRICUM AC., PHOSPHORUS, PHYTOLACCA, SEPIA, SILICEA, SULPHUR, SULPHURICUM AC., ZINC. MET., APIS MEL., THUJA OCC. | Newton Laboratories, Inc. | 9b4276af-b738-3293-e053-2a95a90ad022 | 2025-08-19 | Warnings | O40UQP6WCF |
| Jacksons Cell Salts NAT MUR 6X 9 | NATRUM MURIATICUM | Zettl Health Inc. | 3cbe47fc-db38-e6e9-e063-6294a90a3f1c | 2025-08-19 | Warnings | 451W47IQ8X |
| QUALITY CHOICE SALINE | SODIUM CHLORIDE | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) | f51491d8-12ad-4b1b-a171-c621bfdcc341 | 2025-08-12 | Warnings | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Henry Schein, Inc. | e0466bb3-6c26-4044-b051-69f48b67f632 | 2025-08-07 | Adverse reactions | 451W47IQ8X |
| Schuessler Tissue Salts Nat Mur Fluid Balance 9 | NATRUM MURIATICUM | Martin & Pleasance Pty Ltd | 08da6353-9625-4e8f-8575-a2b49f5d2ac6 | 2025-08-04 | Warnings | 451W47IQ8X |
| Gout Relief 3310-S | CELERY SEED, MEDICAGO SATIVA WHOLE,CHICORY ROOT | Bispit Canada Ltd. | 3afaa7d9-3de3-52d9-e063-6294a90a54ec | 2025-08-02 | Warnings | 451W47IQ8X |
| QUALITY CHOICE SALINE | PLUS SOOTHING ALOE | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) | 4ae4e88a-aaa5-4195-bedc-622fd5cd9394 | 2025-07-30 | Warnings | 451W47IQ8X |
| Diphenoxylate Hydrochloride and Atropine Sulfate | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | American Health Packaging | d0a1c80d-6aae-4886-8c25-e2d29ca0836b | 2025-07-30 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| SODIUM CHLORIDE | SODIUM CHLORIDE | Baxter Healthcare Corporation | 9e72418a-376e-4637-99ad-d13c904a7986 | 2025-07-30 | Warnings, Adverse reactions | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.